Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Award

C3 AI Named to Constellation ShortListtm for Cloud-Based Data Science & Machine Learning Platforms


C3 AI (NYSE: AI), the Enterprise AI application software company, today announced it was named to the Constellation ShortListtm for Cloud-Based Data Science & Machine Learning Platforms in Q1 2024, marking the fifth year in a row Constellation Research has recognized the C3 AI Platform as a "solution to know."

"Year over year, recognition on Constellation's ShortLists continue to reinforce C3 AI's leadership and first mover position in a rapidly expanding and increasingly competitive enterprise software market," said C3 AI CEO and Chairman Thomas M. Siebel. "Our focus remains constant: delivering safe, secure, and effective enterprise AI solutions that drive transformative digital transformation and help our customers realize immense economic benefit."

Constellation Research spotlighted the unique capabilities and benefits of the C3 AI Platform ? a scalable, end-to-end platform that enables organizations to quickly design, develop, and deploy enterprise AI applications ? out of more than a dozen solutions currently available in the market. Organizations across industries leverage the C3 AI Platform to provide predictive insights that improve business operations, ranging from mitigating supply chain risk to predicting maintenance needs.

The ShortList features technology vendors and service providers that deliver critical transformation initiative requirements for early adopters and fast-follower organizations.

"Constellation's ShortLists play a critical role in accelerating technology buying decisions, and with vendors accelerating their AI capabilities, clients expect our analysts to identify the vendors with real solutions ready for the market," said R "Ray" Wang, chairman and founder at Constellation Research. "Buy-side clients trust that our analysts have identified the best vendors in each category, including C3 AI and its standout cloud-based ML platform that delivers comprehensive data science tools for developing, deploying, and delivering advanced AI applications quickly."

Constellation Research advises leaders on leveraging disruptive technologies to achieve business model transformation and streamline business processes. Products and services named to the Constellation ShortList meet the threshold criteria for this category as determined through client inquiries, partner conversations, customer references, vendor selection projects, market share, and internal research. The portfolio is updated at least once per year as the analyst team deems necessary based on market conditions.

About C3.ai, Inc.

C3 AI is the Enterprise AI application software company. C3 AI delivers a family of fully integrated products including the C3 AI Platform, an end-to-end platform for developing, deploying, and operating enterprise AI applications, C3 AI applications, a portfolio of industry-specific SaaS enterprise AI applications that enable the digital transformation of organizations globally, and C3 Generative AI, a suite of large AI transformer models for the enterprise.

Disclaimer

Constellation Research does not endorse any solution or service named in its research.

Note: Additional Constellation Research promotional resources available here.


These press releases may also interest you

at 09:05
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:05
F5 announced that it has been singled out as a visionary in API security for its F5 Distributed Cloud Web App and API Protection (WAAP) in Enterprise Management Associates' Vendor Vision 2024 report. The report highlights "must see" security...

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 08:00
Gateway Fiber's high-speed 100% fiber internet is branching out to...

at 02:34
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...



News published on and distributed by: